Search…

    Saved Articles

    You have not yet added any article to your bookmarks.

    Browse

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    OpenAI and the FDA are reportedly discussing AI for drug evaluations

    5 days ago

    OpenAI has met with officials from the U.S. Food and Drug Administration to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the report, OpenAI and the FDA have discussed a project called cderGPT, which seems to be an AI tool for the Center for Drug Evaluation […]
    Click here to Read more
    Prev Article
    Tesla’s  ‘Robotaxi’ and ‘Cybercab’ trademarks hit roadblocks ahead of June launch
    Next Article
    The Papal ‘conclave cam’ is slow TV

    Related Technology Updates:

    Comments (0)

      Leave a Comment